The value of signs, symptoms and plasma heart-type fatty acid-binding protein (H-FABP) in evaluating patients presenting with symptoms possibly matching acute coronary syndrome: background and methods of a diagnostic study in primary care

BMC Family Practice
Robert T A WillemsenGeert Jan Dinant

Abstract

Chest complaints presented to a general practitioner (GP) are frequently caused by diseases which have advantageous outcomes. However, in some cases, acute coronary syndrome (ACS) is present (1.5-22% of cases). The patient's signs, symptoms and electrocardiography results are insufficient diagnostic tools to distinguish mild disease from ACS. Therefore, most patients presenting chest complaints are referred to secondary care facilities where ACS is then ruled out in a majority of patients (78%). Recently, a point of care test for heart-type fatty acid-binding protein (H-FABP) using a low cut-off value between positive and negative of 4 ng/ml has become available. We aim to study the role of this point of care device in triage of patients presenting chest complaints possibly due to ACS, in primary care. Our research protocol is presented in this article. Results are expected in 2015. Participating GPs will register signs and symptoms in all patients presenting chest complaints possibly due to ACS. Point of care H-FABP testing will also be performed. Our study will be a derivation study to identify signs and symptoms that, combined with point of care H-FABP testing, can be part of an algorithm to either confirm or rule out ACS. T...Continue Reading

References

Apr 1, 1992·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J A Knottnerus
May 30, 1998·QJM : Monthly Journal of the Association of Physicians·J Chambers, C Bass
Mar 27, 1999·Annals of Emergency Medicine·I G Stiell, G A Wells
Jun 29, 2000·JAMA : the Journal of the American Medical Association·T G McGinnW S Richardson
Aug 30, 2000·International Journal of Cardiology·F H RuttenA W Hoes
Nov 15, 2003·Journal of Clinical Epidemiology·J A Knottnerus, J W Muris
Feb 26, 2004·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·Gail Ann DeLuca Havens
Jun 9, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jim ChristensonJoel Singer
Jan 20, 2005·Heart·S GoodacreJ Nicholl
Nov 24, 2005·JAMA : the Journal of the American Medical Association·Clifford J Swap, John T Nagurney
Nov 1, 2007·Family Practice·Maren Abu HaniNorbert Donner-Banzhoff
Mar 1, 2008·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Rudi BruyninckxFrank Buntinx
Aug 4, 2009·BMC Family Practice·Rudi BruyninckxBert Aertgeerts
Dec 29, 2009·Resuscitation·Richard BodyKevin Mackway-Jones
Jan 7, 2011·The American Journal of Emergency Medicine·C Geraldine McMahonS Peter Fitzgerald
Mar 16, 2011·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Frank BuntinxGeert-Jan Dinant
Jun 13, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Jörg HaasenritterNorbert Donner-Banzhoff
Aug 28, 2012·European Heart Journal·UNKNOWN Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Doron Zahger
Aug 28, 2012·Circulation·Kristian ThygesenShanti Mendis
Jan 19, 2013·Journal of Thrombosis and Thrombolysis·Christian T RuffDavid A Morrow
Sep 5, 2013·International Journal of Cardiology·Madeleine H E Bruins SlotFrans H Rutten

❮ Previous
Next ❯

Citations

Jun 27, 2017·Scandinavian Journal of Clinical and Laboratory Investigation·Luisa AgnelloMarcello Ciaccio
Dec 3, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Sarah WalkerWilliam Hamilton
Jan 21, 2019·The International Journal of Cardiovascular Imaging·Mohammadreza Taban SadeghiMahboub Pouraghaei

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01826994

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.